ONCT:US
$0.527
-
0.00%
Oncternal Therapeutics Inc.News & Events
Last updated: Nov 5, 2025, 5:30 AM ET
Oncternal Therapeutics Announces the Sale of Select Development Programs and the Wind-Down of its Operations
GlobeNewswire JUL 1, 2025 8:00 AM EDTSAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. today announced the sal...Read ArticleOncternal Therapeutics Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
GlobeNewswire MAR 7, 2025 4:05 PM ESTSAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT) (the &#...Read ArticleMilestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
Canada Newswire SEP 22, 2020 7:00 AM EDTMilestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments ...Read ArticleEquities on the Move - Research on GTX Inc, Juniper Pharmaceuticals, Catabasis Pharmaceuticals and Amber Road
ACCESS Newswire DEC 1, 2015 9:05 AM ESTNEW YORK, NY / ACCESSWIRE / December 1, 2015 / Moments ago, Trader's Choice released new res...Read Article